Related Experiment Video
Updated: Jun 9, 2025

11:54
Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
8.9K
Proteome profiling of polyomavirus nuclear replication centers using iPOND
Kimberly D Erickson1, Erika S Langsfeld1, Alexandra Holland1
1The BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Journal of Virology
|October 31, 2024
Summary
Researchers identified key host proteins essential for polyomavirus (PyV) DNA replication using iPOND-MS. This discovery helps distinguish replication factors from those involved in downstream processing, potentially revealing new therapeutic targets.
Area of Science:
- Virology
- Molecular Biology
- Cellular Biology
Background:
- Polyomaviruses (PyVs) are known to cause various diseases in mammals.
- PyVs rely on host nuclear factors for viral genome replication and transcription.
- The complete set of viral and host proteins involved in PyV replication, known as the replisome, is not fully understood.
Purpose of the Study:
- To identify host proteins that bind to murine polyomavirus (MuPyV) DNA during and after synthesis.
- To differentiate host factors critical for MuPyV DNA replication versus those involved in later processing stages.
Main Methods:
- Utilized the Isolation of Proteins on Nascent DNA coupled with Mass Spectrometry (iPOND-MS) technique.
- Analyzed proteins bound to MuPyV DNA immediately after synthesis and at 2 hours post-synthesis.
Main Results:
- Identified novel MuPyV DNA interactors on newly synthesized viral DNA (vDNA), including MCM complex members, DNA primase, DNA polymerase alpha, DNA ligase, and replication factor C.
- Observed that host and viral proteins bound to MuPyV DNA at 2 hours post-synthesis differed from those on newly synthesized vDNA, with a lack of many replication proteins.
Conclusions:
- The study distinguishes between host factors essential for MuPyV DNA replication and those involved in downstream processing.
- Understanding these host-viral interactions may lead to the identification of therapeutic targets to suppress PyV replication.

